Viewing Study NCT05205161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:09 PM
Ignite Modification Date: 2026-01-29 @ 4:07 AM
Study NCT ID: NCT05205161
Status: TERMINATED
Last Update Posted: 2025-01-07
First Post: 2022-01-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Open-label, View
None Dose Escalation View
None Dose Expansion, View
None Multicentre Study View
None Anticancer View
None Pegylated poly-L-lysine dendrimer View